Agbro Pharmaceuticals Private Limited

Agbro Pharmaceuticals Private Limited - healthcare in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN U74900KA2011PTC057449 Incorporated 07 March 2011 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company healthcare
Revenue · FY 2021
₹17.53 Lakh
▼ 28% YoY
Net profit · FY 2021
₹9,499
Net margin 0.5%
EBITDA · FY 2021
₹54,558
EBITDA margin 3.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Agbro Pharmaceuticals Private Limited

Data last updated:

Agbro Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 07 March 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U74900KA2011PTC057449. Its GSTIN is 06AAJCA2907N1ZI (Haryana).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gulshan Kumar Sharma and Priyanka Kashyap.

Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Vega 503 Fjr Verity Apartment Kasavanahalli, Bangalore, Karnataka, India – 560035.

As per the financials filed for FY 2021, the company reported a revenue of ₹17.53 Lakh, a decline of 28% compared to the previous year. For the same year it recorded a net profit of ₹9,499 (net margin 0.5%) and EBITDA of ₹54,558 (EBITDA margin 3.1%). Revenue has declined at a compounded annual rate (CAGR) of 21% over three years and 2% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74900KA2011PTC057449
Registration Number 057449
Incorporation Date 07 March 2011
ROC Bangalore
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Agbro Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Vega 503 Fjr Verity Apartment Kasavanahalli, Bangalore, Karnataka, India – 560035
  • Industry
    Healthcare, Preventive Health Services

To see the full contact details of Agbro Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Agbro Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Agbro Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Agbro Pharmaceuticals Private Limited, buy the company report.

Financials of Agbro Pharmaceuticals Private Limited

FY 2021 filings available

Agbro Pharmaceuticals Private Limited reported revenue of ₹17.53 Lakh (down 28% YoY) for FY 2021.

Revenue · FY 2021
₹17.53 Lakh ▼ 28%
Net profit · FY 2021
₹9,499 margin 0.5%
EBITDA · FY 2021
₹54,558 margin 3.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 28%
3 years · compounded
▲ 21%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▼ 44%
3 years · compounded
▲ 96%
5 years · compounded
▲ 18%

Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 28% fall in the latest year. EBITDA fell 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹54,558
Profit Before Tax
Tax Expense
Net Profit (PAT)₹9,499
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profitability
EBITDA Margin3.1%
Net Profit Margin0.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Agbro Pharmaceuticals Private Limited, buy the company report.

Board of directors of Agbro Pharmaceuticals Private Limited

Agbro Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Gulshan Kumar SharmaDirector07 Mar 201115 Years 8 MonthsCurrent
Priyanka KashyapAdditional Director28 Aug 201214 Years 2 MonthsCurrent

Auditor

Agbro Pharmaceuticals Private Limited is audited by PRAVESH KHATRI AND ASSOCIATES for the financial year 2019.

Auditor firmFinancial yearFirm registration number
PRAVESH KHATRI AND ASSOCIATESFY 2019024918N

Shareholding

The shareholding of Agbro Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Agbro Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Agbro Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Agbro Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
06AAJCA2907N1ZIHaryanaActive01 Jul 2017

To see the full GST registrations and return filing status of Agbro Pharmaceuticals Private Limited, buy the company report.

Recent activity

Agbro Pharmaceuticals Private Limited has 3 board changes on record since 2011: 2 appointments and 1 cessation. The latest: Arun Kumar Sharma ceased to be Director on 28 Aug 2012.

AGM
Agbro Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
Filing
Agbro Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Bangalore.
Ceased
Arun Kumar Sharma ceased to be Director.
Appointed
Priyanka Kashyap was appointed as Additional Director.
Appointed
Gulshan Kumar Sharma was appointed as Director.
Incorporation
07 Mar 2011
Agbro Pharmaceuticals Private Limited was registered on 07 Mar 2011 with Roc Bangalore & aged 15 years 8 months as per MCA records.

Frequently asked questions

Agbro Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 07 March 2011 (15+ years old) and is registered under CIN U74900KA2011PTC057449.

Agbro Pharmaceuticals has 2 current directors:

The latest financial statements of Agbro Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.

The GSTIN of Agbro Pharmaceuticals is 06AAJCA2907N1ZI, registered in Haryana.

The CIN (Corporate Identification Number) of Agbro Pharmaceuticals is U74900KA2011PTC057449. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Agbro Pharmaceuticals was incorporated on 07 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Bangalore.

Arun Kumar Sharma ceased to be Director on 28 Aug 2012. Priyanka Kashyap was appointed as Additional Director on 28 Aug 2012. Gulshan Kumar Sharma was appointed as Director on 07 Mar 2011.

The registered office of Agbro Pharmaceuticals is at Vega 503 Fjr Verity Apartment Kasavanahalli, Bangalore, Karnataka, India – 560035.

Agbro Pharmaceuticals operates in the healthcare industry, in the preventive health services segment.

The compliance status of Agbro Pharmaceuticals is compliant as of 13 July 2026. The company is actively filing with the Registrar of Companies.